CEO SUMMARY: Anatomic pathology groups across the nation must develop effective strategies to address challenges in pricing, intensifying competition, and expensive new technologies. That’s the assertion of three pathology practice administrators who have organized a boot camp in Dallas next month specifically to train other practice administrators and managers. This event will provide administrators from
Tag: american pathology foundation
CEO SUMMARY: It’s an interesting contradiction. On one hand, most pathologists enthusiastically recognize the value that diagnostic testing services provide to the healthcare community. On the other hand, too often it is non-laboratorians who provide the investment capital and entrepreneurial effort required to build the laboratory organization capable of delivering these diagnostic services.
IS THE APPARENT
UROCOR INKS PACT TO MATCH DIAGNOSTICS WITH THERAPEUTICS
HERE’S A PIONEERING EFFORT to more closely link diagnostics and therapeutics into a single product package.
UroCor, Inc. and Mallinckrodt, Inc. signed an agreement that allows Mallinckrodt to sell and distribute UroCor’s new radiation treatment for prostate cancer.
UroCor’s product, ProstaSeed I-125, is a radioactive pellet used in brachytherapy. This
With commercial laboratories pressing hospital laboratories for joint ventures, a unique selling proposition helps. MDS-AutoLab, Inc. of Canada has a different twist. They will not sell you their automated laboratory equipment. Instead, they offer it on a profit-sharing type of arrangement.
MORE ON: MDS-AutoLab…
This profit-sharing arrangement is already part of the regional laboratory venture between Columbia/HCA